Research / ATR / Fundamental state Inspectable configuration
State dimensions Filing 0001558370-20-001217 General Corporate
Debt relative to revenue 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
37.96% · OPTIONAL · VALID
Capex intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.47% · OPTIONAL · VALID
Operating cash generation 67th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.99% · OPTIONAL · VALID
Revenue growth 44th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
3.44% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
13.14% · OPTIONAL · VALID
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
30.58% · CORE · NOT_ENOUGH_HISTORY
Operating margin 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
13.00% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.90% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.84% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 35 states Self-history eligible
Dec 31, 2018 6/9 normalized Level 3 Mar 31, 2019 6/7 normalized Level 3 Jun 30, 2019 6/7 normalized Level 3 Sep 30, 2019 7/7 normalized Level 3 Dec 31, 2019 7/9 normalized Level 3 Mar 31, 2020 7/7 normalized Level 3 Jun 30, 2020 7/7 normalized Level 3 Sep 30, 2020 7/7 normalized Level 3 Mar 31, 2021 7/7 normalized Level 3 Jun 30, 2021 7/7 normalized Level 3 Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Sep 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 153.31%
Current 37.96%
Delta -115.36% Capex Intensity Decreased
Previous 8.85%
Current 8.47%
Delta -0.38% Cash Generation Decreased
Previous 22.71%
Current 17.99%
Delta -4.72% Growth Decreased
Previous 5.33%
Current 3.44%
Delta -1.90% Inventory Pressure Decreased
Previous 54.68%
Current 13.14%
Delta -41.54% Profitability Increased
Previous 12.87%
Current 13.00%
Delta 0.13% Sbc Intensity Increased
Previous 0.73%
Current 0.84%
Delta 0.11% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.